SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?


To: Dr. John M. de Castro who wrote (741)12/28/1999 8:56:00 PM
From: John McCarthy  Read Replies (5) | Respond to of 1494
 
John

<<NTII Director makes an open market purchase.
12/99 NTII DIR ELIOT THEODORE L P 11/09/99 6,250>>

Outstanding news .........

Thanks! for the heads up.

...looking forward to mid/late January and further
news from NTII about their results for:

Phase IIB Trial Of Memantine for Diabetic Peripheral Neuropathy

((fyi to visitors .......
Sept. Enrollment press release ...
biz.yahoo.com ))

regards,
John